Zainab Shinkafi-Bagudu Takes Office as UICC President, Becoming First African to Lead Cancer Union
Dr Zainab Shinkafi-Bagudu has assumed office as President of the Union for International Cancer Control, becoming the first African to lead the organisation.
UICC confirmed that she took office on October 20, 2026, at its General Assembly and will serve for the 2026–2028 term.
She succeeds Ulrika Årehed Kågström.
The milestone follows Shinkafi-Bagudu’s election as UICC President-elect in 2024.
That chronology matters.
She was elected to the future office in 2024 but formally became President in October 2026.
A historic first for Africa
UICC’s own record of past presidents supports Shinkafi-Bagudu’s status as the first African to hold the presidency.
The appointment gives an African cancer advocate a prominent governance role within one of the world’s major international cancer organisations.
It is also a significant milestone for Nigeria, where Shinkafi-Bagudu has spent years working in cancer advocacy and health policy.
What UICC does
The Union for International Cancer Control is an international membership organisation that brings together and supports organisations working across the global cancer community.
Its work includes advocacy, convening, policy engagement and efforts aimed at strengthening cancer prevention, early detection, treatment and care.
The UICC President chairs the organisation’s Board and provides governance leadership.
That role carries influence in global cancer advocacy.
It does not give the President regulatory authority over national health systems.
Why the presidency matters for Africa
The significance of Shinkafi-Bagudu’s presidency goes beyond symbolism.
African countries face a growing cancer burden while many health systems continue to struggle with gaps in screening, diagnosis, specialist care, medicines and treatment infrastructure.
Late diagnosis and unequal access to care remain major challenges in many countries.
An African presidency at UICC creates an opportunity to bring greater visibility to those inequalities.
But representation alone does not guarantee better outcomes.
Progress will still depend on national governments, health institutions, financing, workforce capacity and access to care.
A Nigerian advocate on the global stage
Shinkafi-Bagudu is a paediatrician and cancer-control advocate who has been active in Nigerian and international cancer advocacy.
Her elevation to the UICC presidency gives a Nigerian health advocate a stronger platform in global discussions on cancer prevention, treatment and equity.
For Nigeria, the moment also draws attention back to domestic cancer-control challenges.
These include the cost of treatment, shortages in specialist capacity, late diagnosis and unequal access to screening and care.
The policy question now shifts to impact
Historic appointments matter.
But their policy significance depends on what follows.
For UICC, the key questions are what priorities Shinkafi-Bagudu will pursue during the 2026–2028 term and how strongly the organisation will focus on cancer inequalities affecting low- and middle-income countries.
For Nigeria and other African countries, the question is whether greater representation at the top of a global cancer organisation can help strengthen partnerships, advocacy and attention to cancer-control gaps.
Those outcomes will depend on institutions and policy, not one office-holder alone.
What is verified
UICC confirms that Dr Zainab Shinkafi-Bagudu assumed office as its President on October 20, 2026.
She had been elected President-elect in 2024.
She will serve for the 2026–2028 term.
UICC’s historical presidency record supports her status as the first African to lead the organisation.
The verified development is therefore not a new election.
It is the start of her presidency.
